StockData
Annexon, Inc. logo

Annexon, Inc. (ANNX) stock

ANNXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 5/30
$3.52+0.05 (+1.44%)

Close on Nov 18, 2026Market cap $719.65MP/E –Yield 0.00%

Annexon shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

Annexon's shares outstanding was 201M at Jun 30, 2026. For fiscal 2025 it was 155M, up 12.9% from the year before. The highest annual figure on record is 155M in fiscal 2025.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 2025155M+12.9%
FY2024Dec 31, 2024137M+81.6%
FY2023Dec 31, 202376M+38.4%
FY2022Dec 31, 202255M+42.7%
FY2021Dec 31, 202138M+125.9%
FY2020Dec 31, 202017M+3813.0%
FY2019Dec 31, 20190M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026201M+35.5%
Q1 FY2026Mar 31, 2026194M+31.1%
Q4 FY2025Dec 31, 2025175M+11.5%
Q3 FY2025Sep 30, 2025149M+6.6%
Q2 FY2025Jun 30, 2025148M+14.0%
Q1 FY2025Mar 31, 2025148M+20.7%
Q4 FY2024Dec 31, 2024157M+100.4%
Q3 FY2024Sep 30, 2024140M+85.7%
Q2 FY2024Jun 30, 2024130M+73.0%
Q1 FY2024Mar 31, 2024123M+66.1%
Q4 FY2023Dec 31, 202378M+7.8%
Q3 FY2023Sep 30, 202375M+9.7%
Q2 FY2023Jun 30, 202375M+95.0%
Q1 FY2023Mar 31, 202374M+91.5%
Q4 FY2022Dec 31, 202273M+88.6%
Q3 FY2022Sep 30, 202269M+79.1%
Q2 FY2022Jun 30, 202239M+0.8%
Q1 FY2022Mar 31, 202239M+1.0%
Q4 FY2021Dec 31, 202138M+35.2%
Q3 FY2021Sep 30, 202138M+8739.5%
Q2 FY2021Jun 30, 202138M+8724.9%
Q1 FY2021Mar 31, 202138M+8698.3%
Q3 FY2020Sep 30, 202028M+6462.6%
Q2 FY2020Jun 30, 20200M0.0%
Q1 FY2020Mar 31, 20200M–
Q4 FY2019Dec 31, 20190M–
Q3 FY2019Sep 30, 20190M–
Q2 FY2019Jun 30, 20190M–

More Annexon figures

See a number that looks wrong?